anti-WISP1 antibodies (Sorrento)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-WISP1 antibodies (Sorrento)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCCN family member 4 inhibitors
TargetsCCN family member 4
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSorrento Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSorrento Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A